News
Zacks.com on MSN4m
AZN Q2 Earnings Meet Estimates, Sales Beat as Key Drugs OutperformAstraZeneca’s AZN second-quarter 2025 core earnings of $1.09 per American depositary share (ADS) came in line with the Zacks Consensus Estimate. Core earnings of $2.17 per share rose 10% year over ...
The majority of liver cancer cases could be prevented by reducing levels of viral hepatitis, alcohol consumption and MASLD (metabolic dysfunction-associated steatotic liver disease – previously called ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback